References
- Donatsch P, Abisch E, Homberger M, Traber R, Trapp M, Voges R. A radioimmunoassay to measure Cyclosporin A in plasma and serum samples. J Immunoassay 1981; 2: 19
- Thompson J R, Allen R, Morris P J, Wood R F M. Skin cancer in renal transplant patients treated with Cyclosporin. Lancet 1985; 1: 158
- Chapman J R, Thompson J F, Wood R F M, Morris P J. The problems associated with conversion to cyclosporine immunosuppression in long term renal allograft recipients. Transplant Proc
- Chapman J R, Griffiths D, Harding N, Morris P J. The reversibility of Cyclosporine nephrotoxicity after three months treatment. Lancet 1985; 1: 128
- MacMillan A L, Roberts S O B. Porokeratosis of Mibelli after renal transplantation. Br J Dermatol 1974; 90: 45
- Hardie I E, Strong R W, Hartley L C J, Clunie G J A. Skin cancer in Caucasian renal allograft recipients living in a subtropical climate. Surgery 1980; 87: 177
- Calne R Y, White D J G, Thiru S, Evans D B, McMaster P, Dunn D C, Craddock G N, Pentlow B D, Rolles K. Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet 1978; 2: 1323
- European Multicentre Trial. Cyclosporin A as sole immunosuppressive agent in recipients of kidney allografts from cadaver donors. Lancet 1982; 2: 57
- McCarthy J T, Torres V E, Romero J C, Wochos D N, Velosa J A. Acute intrinsic renal failure induced by in-domethacin. Mayo Clin Proc 1982; 57: 289
- Fan T PD, Lewis G P. Effect of cyclosporin A and inhibition of arachidonic acid metabolism on blood flow and cyclooxygenase products in rat skin allografts. Br J Pharmacol 1984; 81: 361
- Makowka L, Giles T, Falk R E, Moffat F L, Phillips M J, Falk J A. Prevention of cyclosporine induced nephrotoxicity in rat by 16,16 dimethyl prostaglandin E2 Transplant Proc. 1985; 17: 1381